LYVE1 and neoplasm: In contrast, a higher survival rate after DASA+ATO@PLT treatment was observed, which may be attributed to the specific binding of PLTs to tumor cells via the interaction of surface P-selectin with the hyaluronic acid receptor (CD44) expressed on tumor cells, enabling drugs to target the damaged areas [41].